Timothy Bell

Medicine

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 2 papers. Top paper: “A quality‐adjusted survival time without symptoms or toxicities analysis of glasdegib plus low‐dose cytarabine versus low‐dose cytarabine as initial therapy for acute myeloid leukemia in patients who are not considered candidates for intensive chemotherapy”.

A quality‐adjusted survival time without symptoms or toxicities analysis of glasdegib plus low‐dose cytarabine versus low‐dose cytarabine as initial therapy for acute myeloid leukemia in patients who are not considered candidates for intensive chemotherapy

Cancer(2020)10.1002/cncr.33072

N/A

0DataRank · unranked

8 citations

Timothy Bell, Young‐Min Kwon, Joseph C. Cappelleri, Courtney Johnson, Helen Bhattacharyya +3 more

Patient, Family Member and Physician Perspectives and Experiences with AML Treatment Decision-Making

Oncology and Therapy(2022)10.1007/s40487-022-00200-9

N/A

0DataRank · unranked

12 citations

Nigel H. Russell, Loriana Hernandez-Aldama, Charlotte Panter, Timothy Bell, Verna Welch +14 more